A frequent pitfall in clinical practice is to believe that guidelines are validated, but what if the collection of evidence creates a statistical entity that does not exist in real-world clinical practice?...
In this podcast, Mary Looby, PharmD, and Christopher S. King, MD, speak about the use of direct oral anticoagulants for the treatment of venous thromboembolic disease and the duration of anticoagulation...
Rachel Putman, MD, discusses her team's latest research on imaging patterns in predicting interstitial lung abnormalities, the gaps in the research, and lessons learned.
In this podcast, Emily O'Brien, PhD, answers our questions about the objective measures of disease severity that affect quality of life among patients with idiopathic pulmonary fibrosis, how these...
In this podcast, Bhavin Dalal, MD, and Vijay Balasubramanian, MD, talk about controversies in the diagnosis and management of acute pulmonary embolism, including intermediate-risk pulmonary embolism and a...
In this podcast, Shari Barnett Brosnahan, MD, and Bhavin Dalal, MD, talk about venous thromboembolism (VTE) and COVID-19 infection, including the treatment options, clinical challenges, and updates in...
In this commentary, Raymond Chung, MD, from Massachusetts General Hospital, explains why it is key to stage a patient’s disease after an HCV diagnosis—and how to do it.
The COLDICE study examined the effectiveness and safety of a novel, less-invasive approach to sampling lung tissue for the diagnosis of interstitial lung disease compared with the gold-standard surgical...
Biologic therapies have been introduced as new treatment options for patients with severe asthma. Wendy Moore, MD, answered our questions about the research she presented at CHEST2020.
Episode 9: Moderator Jaspal Singh, MD, MHA, MHS, interviews Susan Garwood, MD, and Nina Maouelainin, DO, MBA, about advancements in pulmonary thoracic oncology, including key innovations, important trends,...
